<DOC>
	<DOCNO>NCT02984540</DOCNO>
	<brief_summary>The purpose BEAM study compare effect low-carbohydrate diet lowfat diet adult mild memory loss adult pre-diabetes . The data collect help determine change cognitive function , brain structure function , level certain protein hormone body fluid .</brief_summary>
	<brief_title>Effect Modified Ketogenic-Mediterranean Diet Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>1 . Male postmenopausal female ; 2 . Age 50 85 year inclusive ; 3 . Cognitive diagnosis range cognitively normal `` 'Healthy ' 'AtRisk ' '' mild/moderate cognitive impairment `` MCI/eAD ; '' 4 . Stable medical condition ( generally 3 month prior screen visit ) discretion study physician ; 5 . Stable medication ( generally 4 week prior screen visit ) discretion study physician ; 6 . Able complete baseline assessment ; 7 . HbA1c fast glucose within normal ( Healthy MCI/eAD ) prediabetic ( AtRisk MCI/eAD ) range depend group . 1 . Diagnosis neurodegenerative illness ( except MCI early AD MCI/eAD group ) ; 2 . History clinically significant stroke ; 3 . Current evidence history past year focal brain lesion , head injury loss consciousness DSMIV criterion major psychiatric disorder include psychosis , major depression , bipolar disorder , alcohol substance abuse ; 4 . Sensory impairment ( i.e . : visual auditory ) would preclude participant participate protocol ; 5 . Diabetes require current use diabetes medication ; 6 . Current use cholesterol/lipid lowering medication ; 7 . Clinically significant elevation liver function test ; 8 . Active neoplastic disease ( stable prostate cancer nonmelanoma skin cancer permissible ) ; 9 . History epilepsy seizure within past year ; 10 . Contraindications MRI ( claustrophobia , craniofacial metal implant , pacemaker ) ; 11 . Significant medical illness organ failure , uncontrolled hypertension cardiovascular disease , chronic obstructive pulmonary disease , liver disease , kidney disease ; 12 . Use following medication : anticonvulsant , drug potential interfering CNS effect ( cholinesterase inhibitor memantine ) , medication significant anticholinergic activity , antiparkinsonian medication regular use narcotic analgesic ; 13 . If female , menstruation past 12 month hysterectomy current hormone replacement therapy medication ; 14 . Major digestive disorder , absorption issue , surgery may exacerbate diet change ; 15 . Untreated hypothyroidism B12 deficiency ; 16 . Participants currently use resveratrol , CoQ10 ( coenzyme Q10 ) , coconut oil/other medium chain triglyceridecontaining ( ie : Axona ) supplement , curcumin exclude unless willing discontinue 2 week prior start baseline visit remain study duration .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>